Mixed bag of emotions

For the past 6 months, while researching COVID-19 and finding so many different solutions, I have gone through a myriad of emotions. Looking back, the feeling of being confused has been the most consistent emotion. Confused about the lack of transparency of government agencies, confused about the denial of aerosols and humidity, confused about the misleading studies by virologists, confused about the framing of people, as ‘quacks’ or antidemocratic ‘conspiracy-nuts’, despite their genuine rightful questions and confused about the censorship, and lack of critical journalism, by the Mainstream Media in The Netherlands.

We all have coping mechanisms, mine is data. My attempts to keep a level head are achieved by diving into the data and using the data to weed out the noise and bias. And that is what this post is about. My attempt at finding some truth, using data. I will share some figures, unfiltered, without commentary. I will let you draw your own conclusions.

Safety is achieved through the sum of measures, not one measure

Through my research I have learned, similar to car safety, that a combination of measures achieves the highest safety standard. In the case of respiratory viruses, lower infection rates are achieved by:

  • Social Distancing and Hygiene
  • Use of Humidifiers
  • Use of Air Purifiers
  • Use of UVC Lighting
  • Increased Vitamine D intake
  • Increased overall health (less obesity)
  • A Safe and Effective Vaccine

But it’s certainly not only a vaccine. Its not like that with a car either. As I wrote before: “Anyone just and only selling you seatbelts does not care about your safety, they care about selling seatbelts“. And yet, we are being sold, only, seatbelts. The question is why…

10 facts you need to know

1. Influenza (‘The Flu’) was, up until the coronavirus ‘pandemic’, the dominant cause of respiratory virus sickness and death. The US Center for Disease Control and Prevention (CDC) has reported that Influenza (‘The Flu’) has virtually disappeared. It is widely assumed that the coronavirus has replaced Influenza altogether.

2. According to this article in ProPublica, vaccine development under normal circumstances typically takes about 10 to 15 years. It normally takes this long because the long term effects usually take years of analysis. Now its being crammed into less then 1 year and pharmaceutical companies have negotiated with governments that they won’t be held liable for any negative effects – short or longterm.

3. The vaccine market has grown sixfold over the past 20 years, worth more than $35 billion today, according to AB Bernstein. The global Influenza vaccine market size was $ 4.45 billion US dollars (2019). The average vaccination rate is approximately 38%.

4. Four big players account for about 85% of the market — GlaxoSmithKline, Sanofi, Merck and Pfizer. They basically ‘own’ this market. If the vaccination rate would increase from 38% to 100%, the vaccine revenue, distributed among these 4 companies, would jump 163% to $ 11.71 billion US dollars.

5. According to CNBC, for every $1 invested in vaccination in the world’s 94 lowest-income countries, the net return is $44. That’s a 4,400% return. Drug companies have very high profit margins. And every corporation is looking to reduce paying taxes.

6. According to the Dutch Chamber of Commerce GlaxoSmithKline, Sanofi, Merck and Pfizer have registered a financial holding company in The Netherlands. The Netherlands offers low tax incentives to such companies.

7. Rathenau: Breakdown Annual Revenue of Dutch universities:
– Other income: 8% (€ 0,57 billion)
– Tuition fees: 9% (€ 0,72 billion)
– Contract activities (Commercial Activities): 26% (€ 2,02 billion)
– Direct government income (Government Grants): 57% (€ 4,02 billion)

Corporate activities have increasingly become a bigger portion of university revenue. Per example: The Erasmus University in Rotterdam revenue consisted of 46% Government Grants while contract activities and other income amounted to 45%. Universities would financially collapse without revenue from commercial activities, serving corporate interests.

8. More often then not contract activities of universities result in the publishing of a research papers. With a certain result. Many studies, such as this one, have found that “Corporate interests can drive research agendas away from questions that are the most relevant for public health“.

9. Without exception, all the Dutch universities with a focus on ‘Viro Science’ (Erasmus University being a vocal one), are propagating a vaccine as the only solution to this pandemic. Any other possible and complementary solution, such as: Humidifiers, Air Purifiers, UVC Lighting and Alternative medical treatments are attacked viciously. While universities with little to no ties to ‘Viro Science’, such a University of Delft, are studying and propagating alternative solutions. And not just a vaccine.

10. Dutch Foundation for Public Broadcasting (NPO), operating radio and TV stations, is completely dependent on the subsidies from the Dutch government. Many (regional) newspapers and online outlets are also dependent on government subsidies. Without government funding many of these organizations would collapse.

Summary of the data above

A highly profitable product (Influenza Vaccine), responsible for billions of revenue for 4 companies, has become obsolete and needs to be replaced by another product (Coronavirus Vaccine). If not, pharmaceutical companies will lose significant revenue and profits. If more of the new product is sold, by – for example – a forced vaccination program, revenues and profits would skyrocket up to 163% for these 4 companies. Dutch Virologists from Dutch universities, that are dependent on corporate funding from pharmaceutical companies, are disqualifying any and all ‘competing products’ that aren’t a vaccine. And big profits means more tax income for the country where these companies are (fiscally) registered.

What conclusions do you draw when you read these facts?

Look at the data from the perspective of a Big Pharma CEO (without morals), who typically gets paid based on his companies performance. If you knew you had an obsolete product that was responsible for billions in revenues and profits, what would you do? How would you market your new product? Who would you use for marketing of this new product? How would you deal with these competing (alternative and/or complementary) products? What sort of conversations would you have with the government, that stands to earn significant tax revenues? And what would you ask the government to propagate? And how would a government propagate their propaganda?

Whenever you hear someone promoting a solution; ask yourself, what’s in it for this person?
And always; Follow the Money.

Edsard Ravelli